TUE CLOSE · MAY 26, 2026 | DJIA 50,461.68 ▼ 0.23% · S&P 500 7,517.93 ▲ 0.60% RECORD · NASDAQ 26,656.18 ▲ 1.18% RECORD · STOXX 600 628.01 ▼ 0.60% · 10Y TREAS 4.490% · WTI $93.89 ▼ $2.71 · BRENT $99.58 ▲ 3.6% · GOLD $4,500.40 ▼ $20.60 · EURO $1.1632 · YEN 159.29 | CAPITAL WEALTH MID-WEEK EDITION |
S&P 5007,201.30▼0.40%
NASDAQ25,067.80▼0.19%
RUSSELL 2K2,841.06▼0.53%
STOXX 600605.51▼0.99%
WTI$106.42▲$4.48
BRENT$114.44▲5.8%
GOLD$4,712.40▲1.78%
10Y4.445%▲6.8bp
2Y3.929%▲4.2bp
EURO$1.1693▼0.26%
YEN157.25▼weak
GAS$4.51/gal▲Iran spike
IRANHormuz Strike▼tankers hit
FACTORY ORD+1.5%▲hot
PALANTIRRecord Q▲DoD
STATE FARMCA Penalty▼wildfire
CEREBRAS$3.5B IPO▲AI listing
DJIA48,941.90▼1.13%
S&P 5007,201.30▼0.40%
NASDAQ25,067.80▼0.19%
RUSSELL 2K2,841.06▼0.53%
STOXX 600605.51▼0.99%
WTI$106.42▲$4.48
BRENT$114.44▲5.8%
GOLD$4,712.40▲1.78%
10Y4.445%▲6.8bp
2Y3.929%▲4.2bp
EURO$1.1693▼0.26%
YEN157.25▼weak
GAS$4.51/gal▲Iran spike
IRANHormuz Strike▼tankers hit
FACTORY ORD+1.5%▲hot
PALANTIRRecord Q▲DoD
STATE FARMCA Penalty▼wildfire
CEREBRAS$3.5B IPO▲AI listing
WSJ Editorial
Charges of a Covid Coverup
The Justice Department has indicted a former NIH official for obstructing investigations into virus origins. The editorial frames the moment as a credibility test for U.S. public-health institutions.
WSJ Editorial Board · Review & Outlook · May 1, 2026
What the indictment alleges
According to the editorial, the Justice Department charged former NIH official David Morens with obstructing congressional and inspector-general investigations into the origins of Covid-19. Allegations include using a personal Gmail account to avoid Freedom of Information Act searches, deleting emails relating to NIH funding of EcoHealth Alliance grant work, and instructing other officials to do the same.
EcoHealth Alliance is the U.S. nonprofit that subgranted research to the Wuhan Institute of Virology. The board does not adjudicate the lab-leak versus natural-spillover origin question; it argues that the documentary record was compromised by a senior official and the indictment is the consequence.
Why an advisor pays attention
The portfolio implication is small but worth flagging: institutional credibility on public health affects how clients respond to the next infectious-disease event. If trust is lower, vaccine uptake is slower, hospital utilization is higher, treatment-cycle revenue for pharma is more volatile.
In our healthcare overweight we continue to favor large-cap diversified payers and pharmacy chains (UNH, CVS) over single-product biotech, because diversified businesses absorb credibility shocks without single-product binary outcomes.
What This Means For Your Portfolio
Hold UNH and large-cap diversified healthcare; avoid single-product biotech exposure.
Institutional credibility on public health is now an active issue; diversified businesses absorb shocks better than binary single-product names.
Tickers Mentioned In This Article
- UNHUnitedHealth Group
- CVSCVS Health
- LLYEli Lilly
Want this kind of read on every WSJ edition?
Capital Wealth publishes a daily commentary mapping the day's news to specific portfolio actions.
Today's Commentary
